Cover Image
市場調查報告書

體外受精 (IVF) 市場分析:各治療 (顯微授精,凍結胚移植,胚胎著床前遺傳基因診斷),循環的各類型,各設備,各市場區隔的預測

In-Vitro Fertilization (IVF) Market Analysis by Procedures (Intracytoplasmic Sperm Injection), Frozen Embryo Replacement, Pre-implantation Genetic Diagnosis), By Types of Cycles, By Instruments, And Segment Forecasts to 2022

出版商 Grand View Research, Inc. 商品編碼 358138
出版日期 內容資訊 英文 92 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
體外受精 (IVF) 市場分析:各治療 (顯微授精,凍結胚移植,胚胎著床前遺傳基因診斷),循環的各類型,各設備,各市場區隔的預測 In-Vitro Fertilization (IVF) Market Analysis by Procedures (Intracytoplasmic Sperm Injection), Frozen Embryo Replacement, Pre-implantation Genetic Diagnosis), By Types of Cycles, By Instruments, And Segment Forecasts to 2022
出版日期: 2016年05月03日 內容資訊: 英文 92 Pages
簡介

全球體外受精 (IVF) 市場,預計至2022年達到270億美元。

本報告提供全球體外受精 (IVF) 市場相關調查分析,產業預測,各市場區隔預測,加上競爭情形相關的系統性資訊。

第1章 調查手法和範圍

第2章 摘要整理

第3章 體外受精 (IVF) 市場:產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 價值鏈分析
  • 市場動態
    • 推動市場要素分析
    • 阻礙市場要素分析
  • 優先的主要的機會
  • 波特的五力分析
  • PESTEL分析
  • 競爭情形

第4章 體外受精 (IVF) 市場:各治療預測

  • 各治療
  • 顯微授精 (ICSI)
  • 凍結胚移植 (FER)
  • 胚胎著床前遺傳基因診斷 (PGD)
  • 其他

第5章 體外受精 (IVF) 市場:循環的各類型預測

  • 循環的各類型
  • 新鮮捐贈者
  • 新鮮非捐贈者
  • 凍結捐贈者
  • 凍結非捐贈者

第6章 體外受精 (IVF) 市場:各設備預測

  • 各設備
  • 培養基
  • 資本設備
  • IVF拋棄式器具

第7章 體外受精 (IVF) 市場:各地區的預測

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 競爭情形

  • 企業簡介 (企業概要、財務實際成果、產品基準、策略性構想)
    • OvaScience
    • Vitrolife AB
    • EMD Serono, Inc.
    • Irvine Scientific
    • CooperSurgical, Inc.
    • Cook Medical, Inc.
    • Thermo Fisher Scientific, Inc.
    • Genea Biomedx
    • Progyny, Inc.
    • Boston IVF

圖表

目錄
Product Code: 978-1-68038-823-7

Global In-Vitro Fertilization (IVF) market is expected to reach USD 27 billion by 2022, according to a new report by Grand View Research, Inc. The market is driven by the increasing incidence of infertility owing to, lifestyle changes, expansion of fertility procedures for treating male infertility such as ICSI, government initiatives to provide better reimbursement policies, and continuous efforts by the industry contributors.

Moreover, the availability of genomic testing enabling the prevention of the transfer of genetic disease during IVF use is further expected to drive the market demand. The increase in the number of IVF treatment has led more insurance players to cover the IVF procedures. This has ultimately led to competitive pricing and has moderated the treatment costs as IVF has been a successfully practiced technology. This will most likely drive the market by introducing treatment standardization and automation.

The behavioral shift in the society is a major factor contributing to the decreased Total Fertility Rate (TFR). These factors include an increasing number of women in the labor force, the increased age of the first birth, a shift from rural to urban societies, lower marriage rates, postponement of marriage, and greater levels of education for women.

Obesity is another factor, which has led to an increase in infertility in the population. This is due to the fact that the fat deposited on women's abdomen prevents follicular stimulation and produces male hormones. In the case of males, the rising fat decreases testosterone levels causing a problem in sperm production. Doctors have started recommending weight loss in men prior to fertility treatments along with proper Body Mass Index (BMI) maintenance. The U.S. Endocrine Society has established the use of Letrozole to increase the testosterone levels in obese patients.

Further key findings from the report suggest:

Intracytoplasmic Sperm Injection (ICSI) dominated the market in 2014.ICSI was introduced in the year 1992 and boosted the fertility rates from 50% to 80%, according to the American Society for Reproductive Medicine. In April 2016, Nigeria recorded its first successful delivery from a frozen egg. Bridge Clinic has stored the eggs using the flash-freezing technique. With this birth, Nigeria has put itself on the global map as it now offers IVF through frozen eggs. The eggs were then fertilized using the ICSI technique.

Frozen Embryo Replacement (FER) technique is expected to witness a rapid rise in demand. Conventionally, most embryos were transferred through fresh cycles. However, with technology refinement, the number of frozen embryo transfers and the success rates have increased. Moreover, the policy of freezing the embryos has also reduced the chances of ovarian hyper-stimulation. The frozen embryo transfers enable single egg transfer, thus, giving enough time for the endometrial layer to heal from the medicine stimulation effect. This ensures higher success rates.

Culture media dominated the overall market in terms of revenue in 2014. With the increasing government funding and industrial support for employees for egg/sperm freezing, the demand for cryopreservation and the needed media for it is expected to witness growth. There has been an increase in the research activities undertaken to improve the culture media and to procure maximum boar sperms or eggs, spurring market growth. Moreover, the increasing number of egg/sperm donor banks is expected to drive the demand for sperm, egg, and embryo processing media during the forecast period.

Europe dominated the IVF market in 2014. High quality of treatment offered at the most economical price, and the adherence to medical standards have contributed to its market leadership. In Europe, the NHS covers three IVF cycles and has also started providing coverage for gametes freezing. Moreover, the region is an attraction for international clients as countries, such as Spain, have the highest number of egg donors. The clinics also provide sex identification and other IVF treatments, which are not offered in North America.

North America also accounted for a significant share of the market in 2014. The standardization of procedures through automation, regulatory reforms, government funding for egg/sperm storage, and industry players introducing more IVF treatments are some contributing factors for North America dominating the IVF market.

The presence of favorable reimbursement framework (implementation of USD 50 million 5-year plans by the U.S Department of Defense for sperm/egg freezing coverage) is also expected to drive regional market growth over the next six years. The increasing number of clinics undertaking newer industrial techniques to offer better fertility success rates is also expected to boost the regional market demand.

The demand for IVF treatment is expected to boom in APAC owing to fertility tourism, increasing foreign industries trying to penetrate the economically developing countries and the changing regulatory landscape.

The Asia Pacific Initiative on Reproduction (ASPIRE), the task force of clinicians and scientists is involved in the monitoring and management of fertility and Assisted Reproductive Technology (ART). Such initiatives promote awareness levels thereby, driving growth.

Industry contributors are introducing newer automation to shift the IVF treatment from invasive to a minimally invasive or non-invasive procedure. The industry players are also trying technologies, which can enable older women to have enhanced fertility rates. For instance, in August 2015, OvaScience announced the results of its first published analysis comparing AUGMENT fertility treatment with a standard IVF. The results showed a significantly higher rate of selection and transfer of embryos as compared to the standard treatment.

Some key players in this market includeEMD Serono Inc., Boston IVF, OvaScience, Thermo Fisher Scientific Inc., Vitrolife AB, Irvine Scientific, CooperSurgical, Inc., Cook Medical Inc., Genea Biomedx and Progyny Inc.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. In-Vitro Fertilization (IVF) Market - Industry Summary and Key Buying Criteria, 2012 - 2022

Chapter 3. In-Vitro Fertilization (IVF)Industry Outlook

  • 3.1. In-Vitro Fertilization (IVF) Market Segmentation
  • 3.2. In-Vitro Fertilization (IVF) Market Size and Growth Prospects
  • 3.3. In-Vitro Fertilization (IVF) Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Key Opportunities Prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. In-Vitro Fertilization (IVF) Market PESTEL Analysis, 2014
  • 3.7. Competitive landscape

Chapter 4. In-Vitro Fertilization (IVF)Procedures Outlook

  • 4.1. In-Vitro Fertilization (IVF)Market Share by procedures, 2014 & 2022
  • 4.2. Intracytoplasmic Sperm Injection(ICSI) Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 4.3. Frozen Embryo Replacement (FER) Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 4.4. Pre-implantation Genetic Diagnosis (PGD) Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 4.5. Others Market Estimates and Forecasts, 2012 - 2022 (USD Million)

Chapter 5. In-Vitro Fertilization (IVF) Type of Cycles Outlook

  • 5.1. In-Vitro Fertilization (IVF) Market Share by type of cycles, 2014 & 2022
  • 5.2. Fresh Donor Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 5.3. Fresh Non-donor Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 5.4. Frozen Donor Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 5.5. Frozen Non-donor Market Estimates And Forecasts, 2012 - 2022 (USD Million)

Chapter 6. In-Vitro Fertilization (IVF) Instruments Outlook

  • 6.1. In-Vitro Fertilization (IVF) Market Share by instruments, 2014 & 2022
  • 6.2. Culture media Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 6.3. Capital equipment Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 6.4. IVF disposable devices Market Estimates and Forecasts, 2012 - 2022 (USD Million)

Chapter 7. In-Vitro Fertilization (IVF)Regional Outlook

  • 7.1. North America
    • 7.1.1. North America In-Vitro Fertilization (IVF) Market Estimates And Forecasts, By Procedures, 2012 - 2022 (USD Million)
      • 7.1.1.1. U.S. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.1.1.2. Canada Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 7.1.2. North America In-Vitro Fertilization (IVF) Market Estimates And Forecasts, By Type of Cycles, 2012 - 2022 (USD Million)
      • 7.1.2.1. U.S Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.1.2.2. Canada Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 7.1.3. North America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million)
      • 7.1.3.1. U.S. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.1.3.2. Canada Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 7.2. Europe
    • 7.2.1. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 - 2022 (USD Million)
      • 7.2.1.1. UK Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.2.1.2. France Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.2.1.3. Germany Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 7.2.2. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 - 2022 (USD Million)
      • 7.2.2.1. UK Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.2.2.2. France Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.2.2.3. Germany Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 7.2.3. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million)
      • 7.2.3.1. UK Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.2.3.2. France Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.2.3.3. Germany Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 7.3. Asia Pacific
    • 7.3.1. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 - 2022 (USD Million)
      • 7.3.1.1. India Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.3.1.2. China Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.3.1.3. Japan Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 7.3.2. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 - 2022 (USD Million)
      • 7.3.2.1. India Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.3.2.2. China Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.3.2.3. Japan Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 7.3.3. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million)
      • 7.3.3.1. India Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.3.3.2. China Market Estimates and Forecasts, 2012 - 2022 (USD Million)
      • 7.3.3.3. Japan Market Estimates and Forecasts, 2012 - 2022 (USD Million)
  • 7.4. Latin America
    • 7.4.1. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 - 2022 (USD Million)
      • 7.4.1.1. Mexico market estimates and forecasts, 2012 - 2022 (USD Million)
      • 7.4.1.2. Brazil market estimates and forecasts, 2012 - 2022 (USD Million)
    • 7.4.2. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 - 2022 (USD Million)
      • 7.4.2.1. Mexico market estimates and forecasts, 2012 - 2022 (USD Million)
      • 7.4.2.2. Brazil market estimates and forecasts, 2012 - 2022 (USD Million)
    • 7.4.3. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million)
      • 7.4.3.1. Mexico market estimates and forecasts, 2012 - 2022 (USD Million)
      • 7.4.3.2. Brazil market estimates and forecasts, 2012 - 2022 (USD Million)
  • 7.5. MEA
    • 7.5.1. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 - 2022 (USD Million)
      • 7.5.1.1. South Africa Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 7.5.2. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 - 2022 (USD Million)
      • 7.5.2.1. South Africa Market Estimates and Forecasts, 2012 - 2022 (USD Million)
    • 7.5.3. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million)
      • 7.5.3.1. South Africa Market Estimates and Forecasts, 2012 - 2022 (USD Million)

Chapter 8. Competitive Landscape

  • 9.1 OvaScience
    • 9.1.1 Company Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Benchmarking
    • 9.1.4 Strategic Initiatives
  • 9.2 Vitrolife AB
    • 9.2.1 Company Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Benchmarking
    • 9.2.4 Strategic initiatives
  • 9.3 EMD Serono, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Products Benchmarking
    • 9.3.4 Strategic initiatives
  • 9.4 Irvine Scientific
    • 9.4.1 Company Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Benchmarking
    • 9.4.4 Strategic initiatives
  • 9.5 CooperSurgical, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Products Benchmarking
    • 9.5.4 Strategic initiatives
  • 9.6 Cook Medical, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Benchmarking
    • 9.6.4 Strategic initiatives
  • 9.7 Thermo Fisher Scientific, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Products Benchmarking
    • 9.7.4 Strategic initiatives
  • 9.8 Genea Biomedx
    • 9.8.1 Company Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Benchmarking
    • 9.8.4 Strategic Initiatives
  • 9.9 Progyny,Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Benchmarking
    • 9.9.4 Strategic Initiatives
  • 9.10 Boston IVF
    • 9.10.1 Company Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Benchmarking
    • 9.10.4 Strategic Initiatives

List of Tables

  • 1. In-Vitro Fertilization (IVF) Market - Industry Summary & Key Buying Criteria, 2012 - 2022
  • 2. In-Vitro Fertilization (IVF) Market, by Procedures, 2012 to 2022 (USD million)
  • 3. In-Vitro Fertilization (IVF) Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 4. In-Vitro Fertilization (IVF) Market, by Instruments, 2012 to 2022 (USD million)
  • 5. In-Vitro Fertilization (IVF) Market, by Region, 2012 to 2022 (USD million)
  • 6. In-Vitro Fertilization (IVF) Market - Key Market Drivers Analysis
  • 7. In-Vitro Fertilization (IVF) Market - Key Market Restraints Analysis
  • 8. North America Market, by Procedures, 2012 to 2022 (USD million)
  • 9. North America Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 10. North America Market, by Instruments, 2012 to 2022 (USD million)
  • 11. U.S. Market, by Procedures, 2012 to 2022 (USD million)
  • 12. U.S. Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 13. U.S. Market, by Instruments, 2012 to 2022 (USD million)
  • 14. Canada Market, by Procedures, 2012 to 2022 (USD million)
  • 15. Canada Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 16. Canada Market, by Instruments, 2012 to 2022 (USD million)
  • 17. Europe Market, by Procedures, 2012 to 2022 (USD million)
  • 18. Europe Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 19. Europe Market, by Instruments, 2012 to 2022 (USD million)
  • 20. UK Market, by Procedures, 2012 to 2022 (USD million)
  • 21. UK Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 22. UK Market, by Instruments, 2012 to 2022 (USD million)
  • 23. France Market, by Procedures, 2012 to 2022 (USD million)
  • 24. France Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 25. France Market, by Instruments, 2012 to 2022 (USD million)
  • 26. Germany Market, by Procedures, 2012 to 2022 (USD million)
  • 27. Germany Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 28. Germany Market, by Instruments, 2012 to 2022 (USD million)
  • 29. Asia Pacific Market, by Procedures, 2012 to 2022 (USD million)
  • 30. Asia Pacific Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 31. Asia Pacific Market, by Instruments, 2012 to 2022 (USD million)
  • 32. Japan Market, by Procedures, 2012 to 2022 (USD million)
  • 33. Japan Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 34. Japan Market, by Instruments, 2012 to 2022 (USD million)
  • 35. China Market, by Procedures, 2012 to 2022 (USD million)
  • 36. China Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 37. China Market, by Instruments, 2012 to 2022 (USD million)
  • 38. India Market, by Procedures, 2012 to 2022 (USD million)
  • 39. India Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 40. India Market, by Instruments, 2012 to 2022 (USD million)
  • 41. Latin America Market, by Procedures, 2012 to 2022 (USD million)
  • 42. Latin America Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 43. Latin America Market, by Instruments, 2012 to 2022 (USD million)
  • 44. Mexico Market, by Procedures, 2012 to 2022 (USD million)
  • 45. Mexico Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 46. Mexico Market, by Instruments, 2012 to 2022 (USD million)
  • 47. Brazil Market, by Procedures, 2012 to 2022 (USD million)
  • 48. Brazil Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 49. Brazil Market, by Instruments, 2012 to 2022 (USD million)
  • 50. MEA Market, by Procedures, 2012 to 2022 (USD million)
  • 51. MEA Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 52. MEA Market, by Instruments, 2012 to 2022 (USD million)
  • 53. South Africa Market, by Procedures, 2012 to 2022 (USD million)
  • 54. South Africa Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 55. South Africa Market, by Instruments, 2012 to 2022 (USD million)

List of Figures

  • 1. In-Vitro Fertilization (IVF) Market Segmentation
  • 2. Global In-Vitro Fertilization (IVF) Market Revenue, 2012 - 2022
  • 3. In-Vitro Fertilization (IVF) Market Dynamics
  • 4. Key Opportunities Prioritized
  • 5. In-Vitro Fertilization (IVF) Market Analysis - Porter's
  • 6. In-Vitro Fertilization (IVF) Market Analysis - PESTEL Analysis
  • 7. Global In-Vitro Fertilization (IVF)Market, By Procedures, 2012 to 2022 (USD million)
  • 8. Intracytoplasmic Sperm Injection(ICSI) Market, 2012 to 2022 (USD million)
  • 9. Frozen Embryo Replacement (FER) Market, 2012 to 2022 (USD million)
  • 10. Pre-implantation Genetic Diagnosis (PGD)Market, 2012 to 2022 (USD million)
  • 11. Global In-Vitro Fertilization (IVF) Market, By Type of Cycles, 2012 to 2022 (USD million)
  • 12. Fresh Donor Market 2012 to 2022 (USD million)
  • 13. Fresh Non-donor Market 2012 to 2022 (USD million)
  • 14. Frozen Donor Market 2012 to 2022 (USD million)
  • 15. Frozen Non-donor Market 2012 to 2022 (USD million)
  • 16. Global In-Vitro Fertilization (IVF) Market, By Instruments, 2012 to 2022 (USD million)
  • 17. Culture Media Market 2012 to 2022 (USD million)
  • 18. Capital Equipment Market 2012 to 2022 (USD million)
  • 19. IVF Disposable Devices Market 2012 to 2022 (USD million)
  • 20. Global In-Vitro Fertilization (IVF)Market, By Region 2012 to 2022 (USD million)
  • 21. North America Market, by Procedures, 2012 to 2022 (USD million)
  • 22. North America Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 23. North America Market, by Instruments, 2012 to 2022 (USD million)
  • 24. U.S. Market, by Procedures, 2012 to 2022 (USD million)
  • 25. U.S. Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 26. U.S. Market, by Instruments, 2012 to 2022 (USD million)
  • 27. Canada Market, by Procedures, 2012 to 2022 (USD million)
  • 28. Canada Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 29. Canada Market, by Instruments, 2012 to 2022 (USD million)
  • 30. Europe Market, by Procedures, 2012 to 2022 (USD million)
  • 31. Europe Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 32. Europe Market, by Instruments, 2012 to 2022 (USD million)
  • 33. UK Market, by Procedures, 2012 to 2022 (USD million)
  • 34. UK Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 35. UK Market, by Instruments, 2012 to 2022 (USD million)
  • 36. France Market, by Procedures, 2012 to 2022 (USD million)
  • 37. France Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 38. France Market, by Instruments, 2012 to 2022 (USD million)
  • 39. Germany Market, by Procedures, 2012 to 2022 (USD million)
  • 40. Germany Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 41. Germany Market, by Instruments, 2012 to 2022 (USD million)
  • 42. Asia Pacific Market, by Procedures, 2012 to 2022 (USD million)
  • 43. Asia Pacific Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 44. Asia Pacific Market, by Instruments, 2012 to 2022 (USD million)
  • 45. Japan Market, by Procedures, 2012 to 2022 (USD million)
  • 46. Japan Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 47. Japan Market, by Instruments, 2012 to 2022 (USD million)
  • 48. China Market, by Procedures, 2012 to 2022 (USD million)
  • 49. China Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 50. China Market, by Instruments, 2012 to 2022 (USD million)
  • 51. India Market, by Procedures, 2012 to 2022 (USD million)
  • 52. India Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 53. India Market, by Instruments, 2012 to 2022 (USD million)
  • 54. Latin America Market, by Procedures, 2012 to 2022 (USD million)
  • 55. Latin America Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 56. Latin America Market, by Instruments, 2012 to 2022 (USD million)
  • 57. Mexico Market, by Procedures, 2012 to 2022 (USD million)
  • 58. Mexico Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 59. Mexico Market, by Instruments, 2012 to 2022 (USD million)
  • 60. Brazil Market, by Procedures, 2012 to 2022 (USD million)
  • 61. Brazil Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 62. Brazil Market, by Instruments, 2012 to 2022 (USD million)
  • 63. MEA Market, by Procedures, 2012 to 2022 (USD million)
  • 64. MEA Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 65. MEA Market, by Instruments, 2012 to 2022 (USD million)
  • 66. South Africa Market, by Procedures, 2012 to 2022 (USD million)
  • 67. South Africa Market, by Type of Cycles, 2012 to 2022 (USD million)
  • 68. South Africa Market, by Instruments, 2012 to 2022 (USD million)
Back to Top